Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Upgrades DraftKings to Buy, Announces $24 Price Target

BTIG analyst Clark Lampen upgrades DraftKings (NASDAQ:DKNG) from Neutral to Buy and announces $24 price target.

byBenzinga Newsdesk

February 17, 2023

1 minute read

BTIG analyst Clark Lampen upgrades DraftKings (NASDAQ:DKNG) from Neutral to Buy and announces $24 price target.

News

AstraZeneca Collaborates with VaxEquity to Discover and Develop Self-amplifying RNA Therapeutics

By Charles Gross

Today, 10:49 AM

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisastion of the proprietary self-amplifying RNA (saRNA) therapeutics platform developed at Imperial College London.

AZN

New Flyer To Offer Allison’s eGen Flex Electric Hybrid Propulsion System

By Shivani Kumaresan

Today, 10:49 AM

Allison Transmission Holdings Inc (NYSE:ALSN) has announced New Flyer Industries Canada ULC and New Flyer of America Inc (New…

ALSN

Tencent Terminates Exclusive Music Copyright Agreements Post Government Crackdown: Reuters

By Anusuya Lahiri

Today, 10:49 AM

Tencent Holdings Ltd (OTC:TCEHY) has ended all exclusive music copyright agreements after Chinese regulators barred it from such deals…

NTES

M&A
News

Deutsche Bank CEO Says We Would Be Ready For Takeovers In Asset Management When The Moment Has Come

By Benzinga Newsdesk

Today, 10:49 AM

-Reuters

BTIG Upgrades DraftKings to Buy, Announces $24 Price Target

Related Posts

AstraZeneca Collaborates with VaxEquity to Discover and Develop Self-amplifying RNA Therapeutics

New Flyer To Offer Allison’s eGen Flex Electric Hybrid Propulsion System

Tencent Terminates Exclusive Music Copyright Agreements Post Government Crackdown: Reuters

Deutsche Bank CEO Says We Would Be Ready For Takeovers In Asset Management When The Moment Has Come